Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

ImmunoPrecise Antibodies Ltd. - Common Stock (NQ:IPA)

0.4880 -0.0068 (-1.37%)
Streaming Delayed Price Updated: 3:59 PM EDT, May 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ImmunoPrecise Antibodies Ltd. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
Immunoprecise Stock Soars As COVID-19 Antibody Cocktail Shows Neutralizing Activity Against Delta Variant In Animal Study
Immunoprecise Antibodies Ltd (NASDAQ: IPA) has announced new results from its TATX-03 PolyTope Therapy, demonstrating potent pseudovirus neutralizing activity... 
Via Benzinga
Exposures COVID-19
ImmunoPrecise's PolyTope™ TATX-03 Antibody Cocktail Potently Neutralizes SARS-CoV-2 Delta Variant in in vitro Pseudovirus Assays
From ImmunoPrecise Antibodies Ltd.
Via Business Wire
ImmunoPrecise to Report Financial Results and Business Highlights for Fiscal Year 2021
From ImmunoPrecise Antibodies Ltd.
Via Business Wire
Stocks That Hit 52-Week Lows On Friday
Before 10 a.m. ET on Friday, 43 companies set new 52-week lows. Points of Interest: Autohome (NYSE:ATHM) was the largest firm by market cap to set a new 52-week low... 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
During Wednesday's morning session, 29 stocks hit new 52-week lows. Points of Interest: The largest company by market cap to set a new 52-week low was CoStar Gr (... 
Via Benzinga
Eurofins Discovery and ImmunoPrecise Announce Collaboration to Expand their Antibody Discovery Platform
From ImmunoPrecise Antibodies
Via Business Wire
Immunoprecise Share Are Trading Higher On Encouraging Preclinical Data Of COVID-19 Antibody Cocktail
Immunoprecise Antibodies Ltd (NASDAQ: IPA) has announced additional results from its in vivo hamster challenge efficacy study of TATX-03a PolyTope Therapy, a four... 
Via Benzinga
Exposures COVID-19
Histopathology Preclinical Data from ImmunoPrecise’s Polytope™ Program Confirms Lung Inflammation Reduction
From ImmunoPrecise Antibodies
Via Business Wire
Preclinical Data from ImmunoPrecise’s Drug Pipeline to be Presented During the BIO International Partnering Event
From ImmunoPrecise Antibodies
Via Business Wire
ImmunoPrecise Announces Appointment of Dr. Ilse Roodink to the Role of Chief Scientific Officer and Resignation of Dr. Yasmina Abdiche
From ImmunoPrecise Antibodies
Via Business Wire
ImmunoPrecise Names Dr. Dion Neame to Strategic Advisory Board
From ImmunoPrecise Antibodies
Via Business Wire
ImmunoPrecise Moves SARS-CoV-2 PolyTope™ Cocktail Program’s Path Toward IND Filing
From ImmunoPrecise Antibodies
Via Business Wire
ImmunoPrecise Selects LifeSci Advisors as Investor Relations Agent of Record
From ImmunoPrecise Antibodies Ltd.
Via Business Wire
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Greenwich LifeSciences (NASDAQ:GLSI) stock moved upwards by 32.67% to $67.0 during Friday's pre-market session. The company's market cap stands at $860.7... 
Via Benzinga
ImmunoPrecise Launches TATX-112 Antibody Program For Cancer, Alzheimer's Disease
ImmunoPrecise Antibodies Ltd's (NASDAQ: IPA) subsidiary Talem Therapeutics LLC has advanced developing a candidate referred to as TATX-112,... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers 180 Life Sciences (NASDAQ:ATNF) stock increased by 25.09% to $9.92 during Thursday's pre-market session. The market value of their outstanding shares is at $... 
Via Benzinga
ImmunoPrecise Launches TATX-112 Candidate Antibody Program, for the Treatment of Cancer and Alzheimer’s Disease
From ImmunoPrecise Antibodies
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.